Verenium Announces Organizational Change
News Apr 06, 2009
Verenium Corporation has announced that following the successful commissioning of Verenium’s demonstration scale facility in Jennings, Louisiana, and the recent announcement of a commercial joint venture with BP, Verenium is now consolidating its research and development (R&D) organization, including the pilot and demonstration-scale biofuels operations in Jennings, Louisiana, under Gregory Powers, Ph.D., Executive Vice President, R&D.
This new organizational structure provides Verenium with a set of integrated R&D assets from the laboratory through a 1.4 million-gallon-per-year demonstration-scale facility for development, implementation and testing of its biofuels technologies.
As a result of this organizational change, John R. Malloy, Executive Vice President of Biofuels, has left the Company to pursue other opportunities. He will continue to serve as a consultant to the Company.
“I’d like to thank John for his leadership, dedication and significant contributions to Verenium’s biofuels development efforts; we wish him all the best and continued success in his future endeavors,” said Carlos A. Riva, President and Chief Executive Officer of Verenium.
Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These “biologics” can be difficult to obtain and store on the battlefield or in remote areas. That’s why scientists are trying to develop portable systems that can quickly manufacture small batches of protein therapeutics on demand.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019